Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

First To Know Pregnancy Test - Clinical Evaluation Protocol

NCT: NCT07304531 · COMPLETED

NCT IDNCT07304531
StatusCOMPLETED
Start Date2025-10-14
Completion2026-05-07
SponsorNOWDiagnostics, Inc. (INDUSTRY)
First posted
Last updated

Brief Summary

This study is evaluating the ADEXUSDx® hCG CLIA moderately complex, FDA-cleared test for potential over the counter (OTC) use and marketing as the First To Know® (FTK) Pregnancy test. The investigational FTK Pregnancy test will be used to assess its clinical performance in the intended use population (i.e., lay users) through self-testing in a simulated home setting.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑